Skip to content

CAP Supports House Committee’s $46 Billion Fund for COVID-19 Testing and Supplies

Release Date: 11 Feb 2021   |   WASHINGTON
Capitol Hill
WASHINGTON—The College of American Pathologists (CAP) is encouraging Congress to increase resources for testing and expand laboratory capacity in its next COVID-19 relief package. In a letter to House Energy and Commerce Committee leaders, who are marking up the COVID-19 relief bill today, the CAP reiterated its concerns regarding persistent shortages of testing supplies and the need for additional assistance to fight this pandemic.

“Specifically, the CAP supports the committee’s inclusion of $46 billion in funding for COVID-19 testing and the implementation of a testing strategy that supports investments in laboratory capacity,” wrote CAP President Patrick Godbey, MD, FCAP, in the letter to the Energy and Commerce Committee. “In addition to the specified activities outlined by the committee, we would emphasize that these funds should be used for a broad range of tests, including SARS-CoV-2 nucleic acid tests, for a variety of communities and practice settings.”

The CAP has surveyed laboratory directors throughout the pandemic who reported that more testing could be done if they had all the necessary supplies. Laboratory directors have cited problems acquiring testing supplies, particularly test kits, plastic pipette tips, specimen acquisition swabs, and transport media, as the greatest barriers to increased testing.

The CAP also supports the committee’s recommendation to include $1.75 billion in funding for the Centers for Disease Control and Prevention (CDC) related to genomic sequencing of COVID-19 but recommended a broader approach that includes academic medical centers that have the resources to carry out this research. In addition, the CAP supports $7.6 billion in funding for the public health workforce and urged the committee to direct funds for medical examiner offices.

The CAP has also engaged with the Biden administration as it counters the COVID-19 pandemic, especially those elements of the new strategy concerning diagnostic testing.

 

About the College of American Pathologists

As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. As a 501(c)(6) membership organization, the CAP is the only entity representing pathologists with unrestricted advocacy capability and a political action committee, PathPAC. For more information, visit yourpathologist.org to watch pathologists at work and see the stories of the patients who trust them with their care. Read the CAP Annual Report.

 
adding all to cart
False 0
File added to media cart.